Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOXI trial of tecovirimat for mpox infection
NL-OMON60752Phase 4Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tecovirimat in mpox (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Time to complete lesion resolution. Started Jun 2024; status: completed.
02
Drugs
tecovirimat
03
Conditions
mpox
Beyond the preview
Go deeper on NL-OMON60752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60752.